William H. Conrad, Ph.D.

Pharmacology University of Washington, Seattle, Seattle, WA 
Wnt signaling
"William Conrad"
Mean distance: 17.6 (cluster 11)


Sign in to add mentor
Randall Moon grad student 2012 University of Washington
 (Resolving mechanisms of apoptosis in response to WNT3A in Melanoma.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Conrad W, Major MB, Cleary MA, et al. (2013) FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000research. 2: 134
Conrad WH, Swift RD, Biechele TL, et al. (2012) Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation. Cell Cycle (Georgetown, Tex.). 11: 3724-30
Kategaya LS, Changkakoty B, Biechele T, et al. (2009) Bili inhibits Wnt/beta-catenin signaling by regulating the recruitment of axin to LRP6. Plos One. 4: e6129
James RG, Biechele TL, Conrad WH, et al. (2009) Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. Science Signaling. 2: ra25
Louie SH, Yang XY, Conrad WH, et al. (2009) Modulation of the beta-catenin signaling pathway by the dishevelled-associated protein Hipk1. Plos One. 4: e4310
Chien AJ, Conrad WH, Moon RT. (2009) A Wnt survival guide: from flies to human disease. The Journal of Investigative Dermatology. 129: 1614-27
James RG, Conrad WH, Moon RT. (2008) Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors. Methods in Molecular Biology (Clifton, N.J.). 468: 131-44
See more...